SNUBI Research ::   (118 talks satisfying Presenter = )
All  Seminar  BioEMR  xMutant  SysBiol  MAInfo  J.Club  TopicSem  BookReading    This week    Help

ADD NEW USER

:   ǥ:    /Ű:    ¥:   

2014-11:
01 Personalized pharmacogenomics profiling using whole-genome sequencing     J.Club
05 Sg14 sequence interpretation  Seminar
24 Case study of identified adverse drug reaction associated gene with personal genome sequence  TopicSem

2014-10:
15 Case study of identified adverse drug reaction associated gene with personal genome sequence  TopicSem

2014-09:
03 Identified adverse drug reaction associated gene with personal genome sequence - busulfan case  TopicSem
11 Busulfan case reports of identifited ADR associated gene with personal genome sequence  SysBiol

2014-08:
05 Discussion about case study result of ADR related gene detection  SysBiol
09 Network Characteristic Analysis of ADR-related Proteins and Identification of ADR-ADR Associations     J.Club

2014-07:
15 systemetic validation result of ADR gene detection  SysBiol
15 systemetic validation result of ADR gene detection  SysBiol
15 CNV and gene expression profile in 1000 Genomes phase 3 population  SysBiol
30 Summary of pharmacogenomic information about busulfan  TopicSem

2014-06:
02 Case study of identified adverse drug reaction associated gene with personal genome sequence  TopicSem
03 Discussion of validation result of ADR causal gene detection  SysBiol
14 Integrating Systems Biology Sources Illuminates Drug Action     J.Club
24 Discussion of validation result of ADR causal gene detection  SysBiol
30 Validation of identified adverse drug reaction  TopicSem

2014-05:
13 Review and cleansing of DITOP database  SysBiol
30 Identification of adverse drug reaction associated gene with personal genome sequence for deciphering personal ADR outbreak  Seminar

2014-04:
01 Discuss the result of pharmacodynamic sub-module construction related to ADR  SysBiol
02 Constructing pharmacodynamic sub-module to find ADR outbreak mechanism  TopicSem
12 Systematic identification of genomic markers of drug sensitivity in cancer cells     J.Club
28 Identify ADR causal gene with personal genomic variant profile  TopicSem

2014-03:
10 Research for find out mechanism of ADR outbreak  TopicSem
11 Find module related to ADR class in 1000Genome individual  SysBiol

2014-02:
04 Apply CCLE data to personal pharmacogenomics research  SysBiol
05 Research scheme for find out mechanism of ADR outbreak  TopicSem
18 Research to find out ADR mechanism  SysBiol

2014-01:
13 PharmSafe algorithm considering individual genotype & ADR research scheme  TopicSem
20 The Cancer Cell Line Encyclopedia (CCLE) - review and discussion about its personal pharmacogenomic application  SysBiol
25 A Structure-Based Approach for Mapping Adverse Drug Reactions to the Perturbation of Underlying Biological Pathways     J.Club

2013-11:
05 The MedSeq Project : Integration of Whole Genome Sequencing into Clinical Medicine  SysBiol
20 Personal ADR risk ranking based on genome sequencing  TopicSem
30 The Coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system     J.Club

2013-10:
12 Predicting Adverse Drug Reactions Using Publicly Available PubChem BioAssay Data     J.Club
21 Drug database for personal genome interpretation  TopicSem

2013-09:
03 Review and statistics of PharmGKB  SysBiol
23 Circularity problem in PharmRank validation  TopicSem

2013-08:
19 PharmRank case study - Warfarin  TopicSem
24 Using SIFT and PolyPhen to Predict Loss-of-Function and Gain-of-Function Mutations     J.Club

2013-07:
12 PharmRank : Personal genome sequence-based pharmacogenomics drug ranking system for potential adverse drug reactions  Seminar
22 PharmRank : Validation result of drug rank using PPI information  TopicSem

2013-06:
03 Apply drug ranking to 8 SNUBI individuals genome sequence  TopicSem
15 Personal genome related DB review(5) - Genevar  SysBiol
26 Case study of drug rank in 14 1000Genome ethnic population and plan for PharmRank2  TopicSem
29 Improving the Assessment of the Outcome of Nonsynonymous SNVs with a Consensus Deleteriousness Score, Condel     J.Club

2013-05:
04 Literature Based Drug Interaction Prediction with Clinical Assessment Using Electronic Medical Records: Novel Myopathy Associated Drug Interactions      J.Club
06 Personal drug ranking algorithm based on genomic variation  TopicSem

2013-04:
15 Medappllo : Drug ranking forecast algorithm based on personal genomic variation  TopicSem
30 Review of eQTL analysis  SysBiol

2013-03:
04 MedCassandra - validation result of drug rank  TopicSem
16 SNAP: predict effect of non-synonymous polymorphisms on function     J.Club
25 MedCassandra - validation result of drug rank using PPI and pathway information  TopicSem
26 Discussion application SNAP score on genome interpretation  SysBiol

2013-02:
05 MedCassandra : Drug and ADR ranking forecast system based on personal genomic variation  Seminar

2013-01:
19 Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference     J.Club
22 Selection of drug list used in Medcassandra and distribution of damaged drug and gene score  xMutant
28 MedCassandra : Drug ranking in Asian population  TopicSem
31 MedCassandra - apply for new snubi sequence  SysBiol

2012-12:
18 Adjustment of drug and ADR ranking using 1000genome  xMutant
20 Summary of MedCassandra  MAInfo
24 Adjustment of ranking algorithm and Validation of ranking result  TopicSem

2012-11:
13 Statistics and improvement of drug and ADR ranking  xMutant
14 Aplication of pharmacogenomic knowledge to clinic  SysBiol
24 Large-scale prediction and testing of drug activity on side-effect targets     J.Club
26 Drug rank in each therapeutic category and Validation scheme  TopicSem

2012-10:
11 process of drug & ADR ranking calculation  MAInfo
25 Drug database integration for cancer drug research  MAInfo
31 1st result of drug and ADR rank in MedCassandra  TopicSem

2012-09:
13 Drug integration for drug repositioning using ADR  MAInfo
18 Drug and ADR ranking algorithm and validation scheme  xMutant
19 MedCassandra : Personalized ADR ranking forecast system based on personal genomic variation.  TopicSem
22 Identification of chemogenomic features from drug-target interaction networks using interpretable classifiers.     J.Club

2012-08:
01 Review of PharmGKB data open policy  SysBiol
27 Drug Information Retrieval System (DIR)  TopicSem

2012-07:
10 improvement way of ADR ranking algorithm  xMutant
23 MedCassandra – drug information integration for ADR ranking system  TopicSem
28 ranking of multidimensional drug profiling data by fractional adjusted bi-partitional scores     J.Club

2012-06:
16 A pharmacogenomic method for individualized prediction of drug sensitivity     J.Club
25 MedCassandra : Personalized ADR ranking forecast system based on personal genomic variation  TopicSem
28 data extraction for construction of ADR-drug-target relationship  MAInfo

2012-05:
02 Finding repositioning drug candidate among structure-based drug network  TopicSem
07 comparing drug network based on chemical structure vs. gene expression profile simiarlity  xMutant
14 summary of chemical structure based drug repositioning & plan for expression profile based study  TopicSem
25 Prioritization of adverse drug reaction susceptibility based on personal genomic variants  Seminar

2012-04:
09 Clustering and Sub-network analysis of drug structure network  TopicSem
12 Drug repositioning based on adverse drug reaction  MAInfo
13 Drug repositioning based on adverse drug reaction ()  MAInfo
26 using adverse drug reaction data - SIDER  MAInfo

2012-03:
19 Using chemical structure similarity for drug repositioning  TopicSem
24 Systematic Drug Repositioning Based on Clinical Side-Effects     J.Club

2012-02:
02 Interface design & development of drug contraindication agent  BioEMR
02 FusionMap : detecting fusion genes from next-generation sequencing data at base-pair resolution  BioEMR
04 FusionMap : detecting fusion genes from next-generation sequencing data at base-pair resolution     J.Club
15 development of drug drug interaction monitoring agent  TopicSem

2012-01:
18 [completion of replication] Discovery of drug mode of action and drug repositioning from transcriptional responses  TopicSem
19 summary of paper replication work and discuss next step  xMutant

2011-12:
01 [mini-J] Patient-specific electronic decision support reduces prescription of excessive doses.  BioEMR
08 Drug Interaction Monitering Agent - monitoring rule   BioEMR
17 Network neighbors of drug targets contribute to drug side-effect similarity     J.Club
21 drug network clustering and sub-network analysis  TopicSem

2011-11:
16 pharmacology network construction using gene expression profile  TopicSem
16 Drug Interaction Monitering Agent - Overall Workflow and Input Data Generation  BioEMR
17 drug network construction for drug repositioning  xMutant

2011-10:
05 Pharmacology network for drug repositioning  TopicSem
14 Discovery of drug mode of action and drug repositioning from transcriptional responses  BioEMR
22 Discovery of drug mode of action and drug repositioning from transcriptional responses     J.Club
26 Network construction strategy for drug repositioning  TopicSem
27 [mini-j] Strategy for establishing an effective Korean drug utilization review system  BioEMR

2011-09:
08 input of drug use monitoring agent  BioEMR
15 input of drug use monitoring agent development  BioEMR
22 Pharmacology network for drug repositioning  xMutant

2011-07:
02 Pharmacology network for drug repositioning  xMutant
05 drug use monitoring agent plan  BioEMR
14 Pharmacology network for drug repositioning  xMutant
26 ๰ Agent   BioEMR

2011-05:
24 Health Avatar ó (๰ ü )  BioEMR

2011-04:
19 [mini-j] Adverse drug reactions - definitions, diagnosis, and management  BioEMR

powered by SNUBI